• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文学位 >Indirect and direct costs associated with breast cancer related lymphedema treatments.
【24h】

Indirect and direct costs associated with breast cancer related lymphedema treatments.

机译：与乳腺癌相关的淋巴水肿治疗相关的间接和直接费用。

获取原文
获取原文并翻译 | 示例
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Secondary lymphedema associated with breast cancer continues to be an economic challenge for patients. The standard practice of managing breast cancer-related lymphedema (BCRL) does not differentiate between early-stage and advanced stage lymphedema. The purpose of this quantitative analysis was to determine if there was a cost benefit for BCRL patients in either treatment group by combining indirect and direct costs. Secondary data from the National Inpatient Survey 2012 HCUP database was collected from a sample of 149 individuals. The patients who underwent PSM treatment, Loss of Work Charges were positively correlated with Total Hospital Charges (r = .201, p = .041) and Total PSM Costs (r = .203, p = .039). Total Hospital Charges were positively correlated with Total Costs (r = .998, p < .001). The proposed regression model was found to be statistically significant (F(2) = 16099.426, p < .001), with an R2 value of .997. Hospital Charges were found to be a statistically significant predictor of Total PSM costs (beta = 1.004, p < .001). The Hospital Charges were found to have a significant positive relationship with Total TM Costs (r = .991, p < .001). The proposed regression model was found to be statistically significant (F(2) = 1144.925, p < .001), with an R2 value of .982. Hospital Charges were found to be statistically significant predictor of Total TM costs (beta = .977, p < .001). ANOVAs were conducted and it was determined that there were no statistically significant differences between treatment groups.
机译：与乳腺癌相关的继发性淋巴水肿仍然是患者的经济挑战。管理乳腺癌相关淋巴水肿（BCRL）的标准做法无法区分早期和晚期淋巴水肿。这项定量分析的目的是通过组合间接费用和直接费用来确定任一治疗组中BCRL患者是否具有成本效益。 2012年全国住院调查HCUP数据库的二级数据来自149个人的样本。接受PSM治疗的患者，工作费用的损失与医院总费用（r = .201，p = .041）和PSM总费用（r = .203，p = .039）呈正相关。总医院收费与总费用成正相关（r = .998，p <.001）。发现拟议的回归模型具有统计学意义（F（2）= 16099.426，p <.001），R2值为.997。发现医院收费是PSM总费用的统计显着预测因素（β= 1.004，p <.001）。发现医院收费与TM总费用有显着正相关（r = .991，p <.001）。发现建议的回归模型具有统计学意义（F（2）= 1144.925，p <.001），R2值为.982。发现医院收费是TM总费用的统计显着预测因素（β= .977，p <.001）。进行了ANOVA，并且确定在治疗组之间没有统计学上的显着差异。

著录项

  • 作者

    Mahoney, Michelle N.;

  • 作者单位

    Capella University.;

  • 授予单位 Capella University.;
  • 学科 Oncology.;Medicine.
  • 学位 Ph.D.
  • 年度 2015
  • 页码 113 p.
  • 总页数 113
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号